Vol.

171, No.

September

3, 1990

28,

BIOCHEMICAL

AND

ACTIVATION

RESEARCH

COMMUNICATIONS Pages

OF LATENT

BUMAN NEUTROPHIL

OXYGEN SPECIES Herkko

Saari', Yrjij

'IVt"

BIOPHYSICAL

1990

Department

Kimmo

of

AND SWINE

1,3

Suomalainen

, Otso

and Timo

Sorsa2'3

of Medicine,

Helsinki

University

Medical

BY REACTIVE

PROTRASES

T. Konttinen'

Hospital, 'Department

COLLAGENASE

979-987

Helsinki,

Lindyl,

Central

Finland

Chemistry,

University

of

Helsinki,

Finland 3Department

Received

August

of

6,

Periodontology, Helsinki,

University Finland

of

Helsinki,

1990

: The ability of various reactive oxygen species and serine proteases to activate latent collagenase (matrix metalloproteinase-1) purified from human neutrophils was examined. Latent 70-75 kD human neutrophil collagenase (HNC) was efficiently activated by known non-proteolytic activators phenylmercuric chloride (an organomercurial compound) and gold thioglucose(Au(I)-salt). Corresponding degree of activation was achieved by reactive oxygen species including hypochlorous acid (H202) and hydroxyl radical generated WOCl) , hydrogen peroxide by hypoxanthine/xanthine oxidase (HX/XAO). The presence of trace amounts of iron and EDTA were necessary and even enhanced H,O, induced activation of latent HNC. This activation could be abolished by an iron chelator desferrioxamine and a hydroxyl radical scavenger mannitol. HOC1 induced activation of latent HNC was not affected by desferrioxamine and mannitol. Thus, these compounds do not inhibit the active/activated form of HNC. Latent HNC could also be activated by trypsin and chymotrypsin but not by plasmin and plasma kallikrein. The ability of mannitol and desferrioxamine to inhibit the H,O,induced activation of HNC suggests the transition metal dependent Fenton reaction to be responsible for localized and/or site-specific generation of hydroxyl radical/hydroxyl radical -like oxidants to act as the activating oxygen species. Our results support the ability of myeloperoxidase derived HOC1 to act as a direct oxidative activator of HNC and further suggest the existence of a new/alternative oxidative activation O1990 Academic Press,Inc. pathway of HNC involving hydroxyl radical. SUMMARY

Connective such

as

believed

tissue

destruction

rheumatoid

arthritis

to

from

result

in and

the

inflammatory

periodontal

action

of

several

diseases diseases

is

types

of

0006-291X/90 979

$1.50

Copyright 0 1990 by Academic Press, Inc. All rights of reproduction in any form reserved.

BIOCHEMICAL

Vol. 171, No. 3, 1990

proteolytic

enzymes.

capable

of

tissue Although

the

involved

in

are not

3.4.24.7)

(5) *

Concomitantly

in

species

human

exert

neutrophil (6-8). by

of a direct primary

subsequently

proteases extracts

neutrophils

generate

activates effects on latent

role

(HNC)

HNC (6-8).

been

reactive

(5).

oxygen

activity

species

have

especially reported

Furthermore,

of HOC1 on HNC, to

to

reactive

70-75

oxygen

kD HNC purified

both

activation instead

be mediated

cathepsin (8).

been those

(HOCl) has been presented,

HNC proteolytically

of

potential

oxidants,

have

milieu

regulation

of reactive

HOC1 on neutrophil

various

in the

cytotoxic

derived

action of

neutrophils

extracellular

myeloperoxidase,

action

Triggered

to be

the

effects

acid

are considered

to

and

latent

diseases

metalloproteinase-1,

collagenase

oxidative

metalloproteinases

(matrix

a pivotal

Neutrophil

importance.

inflammatory

(l-4).

form

of the

and inhibit

the

enzymes

connective

primary

neutrophils

triggered

of HNC by hypochlorous

here

seen in

a latent

results

generated

the

matrix

microbicidal

Inconsistent

activate

of

collagenase

that

neutrophil's

reported

sources

of the

secrete

E.C.

on

be of

clarified,

source

metalloproteinases

extracellular

to

destruction

completely

of

suggested

cellular

known to

oxygen

are

RESEARCH COMMUNICATIONS

the matrix

a wide range

tissue

a potential are

Among these

degrading

components

AND BIOPHYSICAL

by

G which

We have studied

species from

and

serine

neutral

salt

of human neutrophils. MATERIAL

AND

METHODS

Reasents Native type I collagen was purified from human skin as described (9). Xanthine oxidase (grade III, free of proteolytic impurities) chloride bean (2) I phenylmercuric (PMC) , soy trypsin inhibitor (SBTI), gold thioglucose (GTG), trypsin, chymotrypsin, human plasmin, plasma kallikrein and synthetic serine protease substrates (see below) were purchased from Sigma (St. Louis, Missouri, USA). HOC1 was obtained from the Pharmacy of the University of Helsinki. All other reagents were of the highest commercially available grade. 980

Vol.

171,

No.

3, 1990

Purification qelatinase

BIOCHEMICAL

of

AND

latent HNC serine nrotease

and

BIOPHYSICAL

RESEARCH

and measurement activities

COMMUNICATIONS

of

collaaenase,

Latent 70-75 kD HNC was purified from neutral salt extracts of human neutrophils as described (9,lO). Collagenase activity was measured using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) for separation of the characteristic cleavage products resulting from the action of collagenase on intact native type I collagen. Collagen degradation was quantitated by densitometric scanning of Coomassie brilliant blue stained gels as described (10). Activation of latent collagenase by the organomercurial compound PMC, Au(I)-salt GTG,reactive oxygen species and serine proteases was carried out as described (g-12,21,22). Gelatinase activity was measured using heat denatured type I collagen as substrate at 37OC and the reaction products were analyzed by SDS-PAGE (14). Elastasecathepsin G- and trypsin -like activities were measured using ; mM synthetic substrates, succinyl-alanyl-alanyl-valineparanitroanilide, succinyl-alanyl-alanyl-propyl-phenylalaninebenzoyl-arginine-paranitroanilide, paranitroanilide and respectively, by spectrofotometric recordings at 405 nm as described previously (15).

RESULTS Molecular in

forms

Figures

was

1 and

fractioned molecular

(obtained

after of

and

HNC.

analyzed

fractions with A and

Half

of

activity

HNC

lyophilized

in

From

which

be extracted Hasty

and

the

coeluted (Fig.

from et

described

gelatinolytic

of

latent

activity

to

5)

active

SDS-PAGE.

detected

according used

for

were

collagenase

preparation

free

was

4 and

endogenously

by

shown

corresponding

fractions

could

shown)

lanes

assayed

and

band latent

3 A,

kD were

the

HNC are

fractions

composition

completely

(not

purified

(Fig.

and

70-75

kD protein

band

was

of

protein

Collagenase

purified

studies

HNC S-200

volumes

for

75 kD protein

the

1 mM PMC treatment)

almost

B).

of

Isolated

weight

a 70-75 the

The

3 A.

latency

on Sephacryl

apparent

forms

and

AND DISCUSSION

the al.

1 70-

(16).

activation

serine

protease

activities. Figure

2 demonstrates

HOC1 on latent were

found

10).

Addition

to

the

70-75

kD HNC.

activate

the

of

trace

effects Both

these

latent

amounts

of

1.0

reactive

HNC (Fig. (f-c.

981

mM H,O, and

5pM)

oxygen 2 A,

of

iron

lanes

1.0

mM

species l-4,

7-

and EDTA to

Vol.

171, No. 3, 1990

BIOCHEMICAL

B

AND BIOPHYSICAL

FRACTION

NUMBER

FRACTION

NUMBER

RESEARCH COMMUNICATIONS

Fiqure 1. Fractionation of latent human neutrophil collagenase (LHNC) by Sephacryl S-200. A. Fractions corresponding to apparent Mr of 70-75 kD were assayed for total (PMC+) and endogenous (PMC-) collagenase activity. Dll-12 and al and a2 indicate intact type I collagen dimers and monomers, respectively. Dll-12A and o1A and a2A indicate characteristic 3/4-cleavage products produced by HNC. B. SDS-PAGE analysis of corresponding lyophilizated fractions for protein contents. Molecular weight markers are indicated.

the

incubations

(Fig.

2 A,

both

lanes

(Fig.

inhibit

2 A, lane

Figure the

the 8).

compounds

This

do not

latent

changes

were in detected

The activation

2 A, lanes

activation

70-75

5 and 6),

of

indicates inhibit

latent that

the

apparent after

(Fig.

the

of

HNC induced

compounds did by HOC1 (Fig.

at concentrations

used these form

of H,O,, H,O,-EDTA-FeCl,

3 B,

molecular exposure

982

in

lanes

weight to

HNC by

by desferrioxamine

but these

changes

activation

latent

active/activated

kD HNC; no

observed

HNC enhanced

was inhibited

3 B shows the effects

weight

were

2 and 10).

H,O, and H20,-EDTA-FeCl,

and mannitol not

of H,O, and latent

of

70-75

known

HNC.

and HOC1 on

apparent

8-10).

of

molecular

Similarly,

no

kD latent

HNC

non-proteolytic

Vol.

171,

No.

3, 1990

activators serine be

BIOCHEMICAL

PMC proteases

kallikrein

(Fig.

molecular

weight

2,3,6,7).

The

(13,17,18,22)

being found

was

3,

lanes

kD

latent

(Fig. human

support

by

HNC

the

of

fibroblast-type

operative

on

latent

HNC.

in

ability

5

678

P (1

Among found 3-6),

and

plasma

trypsin in

(Fig.

recent

and

apparent

3 B,

involving

procollagenase Okada of

serine

lanes

documentation

cascade

Also,

to

lanes

plasmin

activation

the

2 B,

changes

human

activator

234

were

Activation

proteolytic

differences

chymotrypsin

incomplete

results

the

(12,14).

with

7-10).

COMMUNICATIONS

4,5)

HNC

with

70-75

present

and

noted

RESEARCH

lanes

latent

associated of

of as

of

2 B,

was

BIOPHYSICAL

trypsin

activation

chymotrypsin

have

(Fig.

activators no

plasmin

GTG

tested,

efficient

whereas

not

and

AND

(19,20) and

Nakanishi

proteases

to

91oH12 PA CZA

BI

234567891o

Figure 2. The effects of H,O,, HzOz-EDTA-FeClz and HOC1 on neutrophil collagenase (LHNC). LHNC (5pg enzyme protein) + 1mM HzO,+type Lane 1. Lane 2. LHNC+lmM HZ02+5pM EDTA+5fiM FeCl,+collagen LHNC+1.5mM H,O,+collagen Lane 3. Lane 4. LHNC+1.5mM H,0,+5pM EDTA+5pM FeCl,+collagen As lane 1+2OmM mannitol+lmM desferrioxamine Lane 5. As lane 4+2OmM mannitol+lmM desferrioxamine Lane 6. LHNC+lmM HOCl+collagen Lane 7. As lane 7+2OmM mannitol+lmM desferrioxamine Lane 8. Lane 9. As lane 1 Lane 10. As lane 2 Lane 11. LHNC+collagen Lane 12. LHNC+lmM PMC+collagen The effects of trypsin, chymotrypsin, plasmin B. kallikrein on LHNC. Tvne I collagen Lane 1. LHNC (5pg enzyme protein)+collagen Lane 2. LHNC (5~4 enzyme protein) treated with Lane 3. molar ratio I:i for 10 min+collagen LHNC treated with trypsin in molar ratio Lane 4. min+collagen 3 and 4, but chymotrypsin Lanes 5 and 6. As lanes as Lanes 7 and 8. As lanes 3 and 4, but plasmin As lanes 3 and 4, but plasma Lanes 9 and 10. activator 011-12 and al and a2 indicate intact type I collagen Rll-12A and alA and respectively. monomers, characteristic 3/4-cleavage products produced by A.

983

latent

human

I collagen

and

plasma

trypsin 1:l

in for

as activator _activator __,_ , KalliKreln

30

as

dimers and a2A indicate HNC.

Vol.

BIOCHEMICAL

171, No. 3, 1990

A 12

kD

kD 5

AND BIOPHYSICAL RESEARCH COMMUNICATIONS

345

7

? 3 4 5 6

8 9 10

9266-

43-

Figure 3. SDS-PAGE A. fractions

analysis during

of

the

protein of

purification

Contents

latent

of

collagenase (LHNC). of human neutrophils Lane 1. Neutral salt extract Lane 2. Sepharose 6-B fraction Lane 3. 0.3 M NaCl-peak/QAE-Sephadex A-50 Lane 4. 0.5 M NaCl-peak/Cibacron Blue Sepharose kD-peakfsephacryl S-200, see also Fig. Lane 5. 70-75 Purification was carried out according to refs. Molecular weight markers are indicated. B. The effects of serine proteases and reactive oxygen on

VariOuS

human neutrophil

1 (9110). species

LHNC.

Lane 1. Lane 2.

LHNC (1Opg enzyme protein) LHNC treated with trypsin in molar ratio 1:l for min Lane 3. As lane 2, but chymotrypsin treatment Lane 4. LHNC treated with 1mMPMC for 30 min Lane 5. LHNC treated with 1.5 mMGTG for 30 min Lane 6. As lane 2, but trypsin treatment for 30 min Lane 7. As lane 3, but chymotrypsin treatment for 30 min Lane 8. LHNC treated with 1 mMH,O, for 30 min Lane 9. LHNC treated with 1mMH,O,-5pM EDTA-5fiM FeCl, for min Lane 10. LHNC treated with 1mMHOC1 for 30 min Molecular weight markers are indicated. act

as matrix

metalloproteinase

metalloproteinases activation

seem

potent

and that

type-specific

the concept

and direct their

activators

activation

proteolytic

activators,

Au(I)-salts

(11,12,20,23).

exclusive

have

(21).

Thus,

30

matrix

proteolytic

pathways.

Our resultssupport are

to

activators

10

inhibition

that of

potential i.e.

reactive

latent

organomercurials

of HNC exposed 984

species

human HNC (5,6,22)

is comparable

Vissers

oxygen

and Winterbourn to reactive

to other and

certain

described oxygen

non-

an

species

Vol.

171, No. 3, 1990

BIOCHEMICAL

However,

(7).

activated

they

by

activator

of

(7).

It

HNC by

species

enzyme

molecule

ability

to

which

then

have

previously

is

noteworthy

involves

the

(20,22).

initially by time

endogenously

activate

the

to

its

that

that

hydroxyl

present

radical

reaction

(24)

peroxide

may react

resulting with

bound

by

of trace

added to can

act

activation amount

enzyme

as

have

the

enzyme, (23).

latent

of

iron,

We

generated

by

HNC to the

same

The present of

iron

incubations

or

catalysts

of

localized

of

itself,

the

amounts

the

HzOZ through

of

the

potential

and GTG (22).

trace

the

of

acetate

from to

form

activates

vivo,

formation

seem to

-system

either

in

group

radical

the presence

metals,

activation and reactive

reactants

catalytic

by

denaturation

thiol

latent

HNC-

activated

Au(I)-salts

these

oxidase

hydroxyl

following

suspectible

All

found

transition

or

HNC completely

once

same critical

may loose

demonstrate

medium

that

rather

as aminophenylmercuric

or other

crude

an organomercurial

organomercurials,

hypoxanthinelxanthine

results

study

the mechanism of the non-proteolytic

oxygen

extent

their acetate,

HNC is

Evidently latent

in

phenylmercuric

organomercurials (23).

used

AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Fenton

HNC. Hydrogen present

in

according

to

the the

reaction: Fe3+ + H,O, + Fe'+ + O,- + 2H+

Ferrous

iron

thus

formed

may then

catalyze

the

Fenton

reaction

as follows: H,O, + Fe 2+ + Fe 3+ + OH- + OH' The hydroxyl collagenase

radical

by cleaving

coordination to cysteic

site acid

(or other

the

of active that

The formation iron

may then

bond between site

zinc

which

radical is able 985

Cysn

activation and the

atom and oxidize

can not be liganded

of hydroxyl

metal)

cause the oxidative

by the requires

to undergo

zinc the redox

of fourth

cysteine atom (20). presence reactions.

of

Vol.

171,

The

No.

3, 1990

BIOCHEMICAL

production

of

endogenous

iron

activation

hydroxyl

present

radicals

Generally, activate

the

suggest specific,

the

well

way

as

other

generation and/or

of be the

neutrophils

simplest to

degranulation enzymes proteolytic cathepsin (5,6,8,9)

of shown

activation

cascades

G;both would

being not

formation

components

necessarily

degrade

may

may,

site very

indeed,

be an

neutrophils

as

activate

their increased radical oxidative

NADPH-oxidase for

triggered

collagenase

contents,

of

to be

locating

mechanism their

than

appropriate

neutrophil

HNC

enzyme.

of hydroxyl

to of

the

The described

direct

granule

participitate

of

involving

activate

to

attack

of

This

activated

specific

random

metal)

oxidants.

endogenously

the

more

means

and most

Thus

endogenously

compensatory

HNC involving

(24).

deficient

to

-like

the

radical

enzyme.

of HzOz and subsequent

activation

be

other

myeloperoxidase

by

rather

hydroxyl

(or

(25)

of

would

of

of the

radical

result

COMMUNICATIONS

catalyzed

solution

would

iron

site

by

hydroxyl

would

by

cells

collagenase

It

be

moiety

reactions

(2).

for

bulk

protein

production

active

alternative

the

such

catalyzed to the

the

RESEARCH

may

may be the

enzyme

that

close

in

on

however,

BIOPHYSICAL

radical

of collagenase

hydroxyl

AND

upon

because

other

non-proteolytic

and

(f.ex.myeloperoxidase, azurophilic

granules)

be required.

Acknowledgments: This work has been financially supported by the Finnish Medical Association Duodecim, the Niilo Helander Foundation, the Finnish Cancer Foundation, the Finnish Cultural Foundation, the Arthritis Foundation in Finland, the Wellcome Foundation and the Oskar ijflunds Foundation. REFERENCES 1. 2. 3.

Werb, Z. (1989) Textbook of Rheumatology, 3rd ed. (Kelley, W.N. et al. eds.), Saunders, Philadelphia pp. 300-309. Sorsa, T., Saari, H., Konttinen, Y. T., Suomalainen, K., Lindy; S., and Uitto, V-J. (1989) Int. J. Tiss. React. 11, 153-159. Sorsa, T., Suomalainen, K., Helenius, J., Lindy, S., Saari, H., Konttinen, Y. T., and Uitto, V-J. (1990) N. Engl. J. Med. 323, 133-134. 986

Vol.

171, No. 3. 1990

4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25.

BIOCHEMICAL

AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Birkedal-Hansen, H. (1988) J. Oral. Pathol. 17, 445-451. Weiss, S. J. (1989) N. Engl. J. Med. 320, 365-376. Weiss, S. J., Peppin, G. J., Ortix, X., Ragsdale, C., and Test, S. T. (1985) Science (Wash. D.C.) 227, 747-749. Vissers, M. C., and Winterbourn, C. C. (1987) Biochem. J. 245, 277-280. Capodici, C. C., and Berg, R. A. (1989) Agents and Action 27, 481-484. Sorsa, T. A. (1987) Stand. J. Rheumatol. 16, 167-175. Sorsa, T., Suomalainen, K., Turto, H., and Lindy, S. (1985) Med. Biol. 63, 66-72. Lindy, S., Sorsa, T., Suomalainen, K., and Turto, H. (1986) FEBS Lett. 208, 23-25 Sorsa, T., Suomalainen, K., Turto, H., and Lindy, S. (1987) Biosci. Rep. 7, 965-968. Uitto, V-J., Suomalainen, K., and Sorsa, T. (1990) J. Periodont. Res. 225, 135-142. Lindy, S., Sorsa, T., Suomalainen, K., and Turto, H. (1988) Stand. J. Rheumatol. suppl. 67, 5-9. Bieth, J., Spiess, B., and Wermuth, C-G-(1974) Biochem. Med. 11, 350-357. Hasty, K. A., Hibbs, M. S., Kang, A. H., and Mainardi, C. L. (1986) J. Biol. Chem. 261, 5645-5650. Ph.D. thesis, University of Helsinki, Sorsa, T. (1989) Finland, ISBN 952-90102-8-l. pp. l-62. Knauper, V., KrZmer, S., Reinke, H., and Tschesche, H. (1990) Eur. J. Biochem. 189, 295-300. Berg, R. A., Capodici, C. C., and D'Armiento, J. (1989) In: Therapeutic approaches to inflammatory diseases (Lewis, M. J. et al. eds.) pp. 84-90. Springman, E. B., Angleton, E-L., Birkedal-Hansen, H., and Van Wart, H. (1990) Proc. Acad. Sci., USA, 87, 364-368. I. (1989) FEBS L&t. 249, 353Okada, Y., and Nakanishi, 356. Sorsa, T., Saari, H., Konttinen, Y. T., Uitto, V-J., and Lindy, S. (1989) N. Engl. J. Med. 321, 327-328. Uitto, V-J., Turto, H., Huttunen, A., Lindy, S., and Uitto, J. (1980) Biochem. Biophys. acta 613, 168-177. Biochem. J. Halliwell, B., and Gutteridge, J. M. (1984) 219, l-14. Klebanoff, S. J. (1988) In: Inflammation: basic principles and clinical correlates (Gallin, J. I. et al. eds.) Raven Press, New York pp. 391-344.

987

Activation of latent human neutrophil collagenase by reactive oxygen species and serine proteases.

The ability of various reactive oxygen species and serine proteases to activate latent collagenase (matrix metalloproteinase-1) purified from human ne...
856KB Sizes 0 Downloads 0 Views